Cargando…

Variability in grading of ductal carcinoma in situ among an international group of pathologists

The prognostic value of cytonuclear grade in ductal carcinoma in situ (DCIS) is debated, partly due to high interobserver variability and the use of multiple guidelines. The aim of this study was to evaluate interobserver agreement in grading DCIS between Dutch, British, and American pathologists. H...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Seijen, Maartje, Jóźwiak, Katarzyna, Pinder, Sarah E, Hall, Allison, Krishnamurthy, Savitri, Thomas, Jeremy SJ, Collins, Laura C, Bijron, Jonathan, Bart, Joost, Cohen, Danielle, Ng, Wen, Bouybayoune, Ihssane, Stobart, Hilary, Hudecek, Jan, Schaapveld, Michael, Thompson, Alastair, Lips, Esther H, Wesseling, Jelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073001/ https://www.ncbi.nlm.nih.gov/pubmed/33620141 http://dx.doi.org/10.1002/cjp2.201

Ejemplares similares

Ductal carcinoma in situ: to treat or not to treat, that is the question
por: van Seijen, Maartje, et al.
Publicado: (2019)

Long-term risk of subsequent ipsilateral lesions after surgery with or without radiotherapy for ductal carcinoma in situ of the breast
por: van Seijen, Maartje, et al.
Publicado: (2021)

Contralateral breast cancer risk in patients with ductal carcinoma in situ and invasive breast cancer
por: Giardiello, Daniele, et al.
Publicado: (2020)

Cause-specific Mortality in a Population-based Cohort of 9799 Women Treated for Ductal Carcinoma In Situ
por: Elshof, Lotte E., et al.
Publicado: (2018)

Pathologic response of ductal carcinoma in situ to neoadjuvant systemic treatment in HER2-positive breast cancer
por: Groen, Emma J., et al.
Publicado: (2021)

Ductal Carcinoma In Situ: What the Pathologist Needs to Know and Why
por: Bane, Anita
Publicado: (2013)

Reliability of preoperative breast biopsies showing ductal carcinoma in situ and implications for non-operative treatment: a cohort study
por: Mannu, Gurdeep S., et al.
Publicado: (2019)

The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study
por: Elshof, Lotte E., et al.
Publicado: (2017)

Microcalcification crystallography as a potential marker of DCIS recurrence
por: Gosling, Sarah B., et al.
Publicado: (2023)

Breast adipocyte size associates with ipsilateral invasive breast cancer risk after ductal carcinoma in situ
por: Almekinders, Mathilde M. M., et al.
Publicado: (2021)

Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women
por: Elshof, Lotte E., et al.
Publicado: (2016)

The impact of patient characteristics and lifestyle factors on the risk of an ipsilateral event after a primary DCIS: A systematic review
por: Alaeikhanehshir, Sena, et al.
Publicado: (2020)

Comprehensive multiplexed immune profiling of the ductal carcinoma in situ immune microenvironment regarding subsequent ipsilateral invasive breast cancer risk
por: Almekinders, Mathilde M., et al.
Publicado: (2022)

Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer
por: Lips, Esther H., et al.
Publicado: (2022)

Unresected screen-detected ductal carcinoma in situ: Outcomes of 311 women in the Forget-Me-Not 2 study
por: Maxwell, Anthony J., et al.
Publicado: (2022)

Comprehensive characterization of pre- and post-treatment samples of breast cancer reveal potential mechanisms of chemotherapy resistance
por: Hoogstraat, Marlous, et al.
Publicado: (2022)

Pathological and Biological Differences Between Screen-Detected and Interval Ductal Carcinoma in situ of the Breast
por: de Roos, Marnix A., et al.
Publicado: (2007)

The presentation, management and outcome of patients with ductal carcinoma in situ (DCIS) with microinvasion (invasion ≤1 mm in size)—results from the UK Sloane Project
por: Shaaban, Abeer M., et al.
Publicado: (2022)

Grading variation in 2,934 patients with ductal carcinoma in situ of the breast: the effect of laboratory- and pathologist-specific feedback reports
por: van Dooijeweert, Carmen, et al.
Publicado: (2020)

Impact of COVID-19 on the practice of breast pathologists: a survey of breast pathologists in the UK and Ireland
por: Elghobashy, Mirna, et al.
Publicado: (2023)

Exploration of utility of combined optical photothermal infrared and Raman imaging for investigating the chemical composition of microcalcifications in breast cancer
por: Bouzy, Pascaline, et al.
Publicado: (2023)

Inter-observer variability between general pathologists and a specialist in breast pathology in the diagnosis of lobular neoplasia, columnar cell lesions, atypical ductal hyperplasia and ductal carcinoma in situ of the breast
por: Gomes, Douglas S, et al.
Publicado: (2014)

Videofluoroscopy Practice in India: A Survey of Speech-Language Pathologists
por: Krishnamurthy, Rahul, et al.
Publicado: (2022)

Treating (low-risk) DCIS patients: What can we learn from real-world cancer registry evidence?
por: Byng, Danalyn, et al.
Publicado: (2021)

Prognostic value of histopathological DCIS features in a large-scale international interrater reliability study
por: Groen, Emma J., et al.
Publicado: (2020)

The diagnosis and management of pre-invasive breast disease: Ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH) – current definitions and classification
por: Pinder, Sarah E, et al.
Publicado: (2003)

Problems for Pathologists
Publicado: (1876)

The Pathologist as Poet
por: Domen, Ronald E.
Publicado: (2016)

To be or not to be an oral pathologist
por: Ramesh, V
Publicado: (2019)

Pathologists’ Fees
Publicado: (1885)

HIMSS10 – Perspectives from a newcomer pathologist and a seasoned attendee pathologist: Pathologists should attend!
por: Carter, Alexis B., et al.
Publicado: (2010)

Cardiovascular Morbidity and Mortality After Treatment for Ductal Carcinoma In Situ of the Breast
por: Boekel, Naomi B., et al.
Publicado: (2014)

Comparative Evaluation of Breast Ductal Carcinoma Grading: A Deep-Learning Model and General Pathologists’ Assessment Approach
por: Köteles, Maria Magdalena, et al.
Publicado: (2023)

Review by urological pathologists improves the accuracy of Gleason grading by general pathologists
por: Nakai, Yasushi, et al.
Publicado: (2015)

Grade of recurrent in situ and invasive carcinoma following treatment of pure ductal carcinoma in situ of the breast
por: Millis, R R, et al.
Publicado: (2004)

Enrichment of high-grade tumors in breast cancer gene expression studies
por: van Seijen, M., et al.
Publicado: (2017)

Association of Clinical Pathologists
Publicado: (2002)

The Relationship of the Pathologist to the Surgeon
Publicado: (1905)

Pathologist to the Edinburgh Infirmary
Publicado: (1902)

The Value of the Pathologist to the Surgeon
por: Davis, E. C.
Publicado: (1911)

Cannot write session to /tmp/vufind_sessions/sess_8bcbfnfg25rd8o9iktk9octgfu